Search clinical trials for: Cisplatin, docetaxel

Total 5120 results

Sanofi

Completed

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

Lung Neoplasms

France, Netherlands, Spain, Turkey, Belgium, Finland, Italy, United Kingdom
Optimal Health Research

Completed

A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.

Breast Cancer | Lung Cancer | Prostate Cancer

United States
Academy Military Medical Science, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Unknown

A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer

Advanced Breast Cancer
Air Force Military Medical University, China

Unknown

Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer

Cervical Cancer

China
National Cancer Center, Korea
Seoul National University Bundang Hospital; Gachon University Gil Medical Center and other collaborators

Unknown

Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer

Gastric Cancer

Korea, Republic of
University of Chicago

Terminated

The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC) (SMART)

Non-small Cell Lung Cancer

United States
Spanish Lung Cancer Group

Terminated

Study to Evaluate Treatment Customized According to RAP80 and BRCA1 in Patients With Advanced Lung Carcinoma (BREC)

Non Small Cell Lung Cancer | BRCA1 Mutation

Spain
Sun Yat-sen University

Recruiting

A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Asan Medical Center

Completed

Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXP

Resected Advanced Gastric Cancer

Korea, Republic of
Hospital of Stomatology, Wuhan University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma (NEOPCOSCC)

Oral Squamous Cell Carcinoma

China
Gyeongsang National University Hospital

Completed

Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Korea, Republic of
Mei Shi

Unknown

Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer

Cervical Cancer | Toxicity Due to Radiotherapy

China
European Lung Cancer Working Party

Terminated

Randomised Study of Concomitant Radiochemotherapy in Non-small Cell Lung Cancer

Non-small Cell Lung Carcinoma

Belgium, France, Spain, Greece
Haruhiko Fukuda
Ministry of Health, Labour and Welfare, Japan

Completed

Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)

Pulmonary Neoplasms

Japan
European Organisation for Research and Treatment...

Completed

Docetaxel and Cisplatin in Treating Patients With Untreated Stage IIIA Non-small Cell Lung Cancer

Lung Cancer

Poland, United Kingdom, Netherlands, Italy, Germany
University Hospital, Antwerp
Universiteit Antwerpen

Completed

Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) (SYRINGES)

Non-Small Cell Lung Cancer

Belgium
Sun Yat-sen University

Recruiting

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Nasopharyngeal Carcinoma | Circulating Tumor Cell | Effects of Chemotherapy | Distant Metastases.Clinical

China
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI); Aventis Pharmaceuticals

Terminated

Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Lung Cancer

United States
Samsung Medical Center

Active, not recruiting

Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study

Salivary Gland Cancer

Korea, Republic of
Peking University People's Hospital

Unknown

Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC

Non-small Cell Lung Cancer

China
Rigshospitalet, Denmark

Completed

Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma

Adrenocortical Carcinoma

Denmark
Sanofi

Completed

Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma (Tax-Nazo)

Head and Neck Neoplasms

Turkey
University Hospital, Antwerp
Sanofi; Universiteit Antwerpen

Completed

Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung Cancer (TOLEDO)

Non-small Cell Lung Cancer

Belgium
AZ-VUB
Sanofi

Unknown

Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Non-Small-Cell Lung Carcinoma

Belgium
Samsung Medical Center

Completed

Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer

Locally Advanced Stage III or IV Thymic Cancer

Korea, Republic of
Guangxi Medical University
Liuzhou Workers Hospital; Wuzhou Red Cross Hospital; Guilin Medical College; People... and other collaborators

Unknown

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery

Lung Cancer

United States
First People's Hospital of Foshan

Unknown

The Value of Single-cycle TPF Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Yonsei University

Completed

Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma

Gastric Cancer

Korea, Republic of
Yung Shin Pharm. Ind. Co., Ltd.
National Cheng-Kung University Hospital; Tri-Service General Hospital; Taichung...

Completed

Post-marketing Surveillance Study of Docetaxel-Based Chemotherapy

Squamous Cell Carcinoma of the Head and Neck | Nonsmall Cell Lung Cancer
Swiss Group for Clinical Cancer Research

Completed

Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery

Esophageal Cancer

Switzerland
Sanofi

Terminated

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Non-Small-Cell Lung Carcinoma

France
Wakayama Medical University

Unknown

Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Cancer

Japan
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Lung Cancer

Switzerland
Chonnam National University Hospital
Chungbuk National University; Chungnam National University; Chonbuk National...

Completed

Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer (TPSHNSCC)

Head and Neck Cancer

Korea, Republic of
Fudan University

Terminated

Study of Weekly DCF to Treat Advanced Gastric Cancer

Gastric Cancer

China
Nanfang Hospital of Southern Medical University

Recruiting

Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal Carcinoma

Cisplatin | NPC | Carboplatin

China
Sanofi

Completed

Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer (TAX200006)

Head and Neck Neoplasms

France
Zhao Chong
Wu Jieping Medical Foundation

Active, not recruiting

The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients

Nasopharyngeal Carcinoma | Malnutrition

China
Sanofi

Completed

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors

Neoplasms, Malignant

Japan
Sun Yat-sen University
Peking University; Zhejiang Cancer Hospital; Xiangya Hospital of Central South... and other collaborators

Not yet recruiting

Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC (NX-NPC)

Nasopharyngeal Carcinoma

China
Mayo Clinic

Active, not recruiting

Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer

Oropharynx Cancer

United States
University of Southern California

Withdrawn

Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer

Lung Cancer
Shantou University Medical College

Unknown

Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer

Pleural Effusion, Malignant

China
National Guard Health Affairs

Terminated

Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer (Customizing)

Non-Small Cell Lung Cancer

Saudi Arabia
Rabin Medical Center
Davidoff Cancer Center

Unknown

Induction Docetaxel/Cisplatin/5-fluorouracil (TPF) as Selector for Chemo Radiation Therapy (RT) Versus Partial Laryngectomy in Advanced Laryngeal Cancer

Larynx Cancer

Israel
Memorial Sloan Kettering Cancer Center
Sanofi; University of Pittsburgh; Medical College of Wisconsin; Weill Medical College... and other collaborators

Completed

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

United States
Sanofi

Completed

Docetaxel in Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Squamous Cell

Austria
King Faisal Specialist Hospital & Research Center

Completed

Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer

Breast Cancer
Zhao Chong
Zhejiang Cancer Hospital; Wuhan University; Fudan University; Fujian Cancer Hospital and other collaborators

Completed

Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients

Nasopharyngeal Carcinoma | Malnutrition

China

3

Subscribe